BackEiger BioPharmaceuticals Overview

Eiger BioPharmaceuticals Inventory

Track Eiger BioPharmaceuticals's inventory ($1.6M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Inventory
$1.56M
↓ 45.46% YoYΔ $-1.30M vs prior year quarter

Peer trimmed avg / median

Loading

Eiger BioPharmaceuticals Inventory History

Loading

Eiger BioPharmaceuticals vs. peers: Inventory Comparison

Loading

Eiger BioPharmaceuticals Inventory Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Eiger BioPharmaceuticals (EIGRQ) FAQ

Eiger BioPharmaceuticals (EIGRQ) currently reports a inventory of $1.6M as of December 2023. That compares with $2.9M in the prior-year period — down 45.5% year over year. Use the charts on this page to explore Eiger BioPharmaceuticals's inventory history and peer comparisons.

Eiger BioPharmaceuticals's inventory decreased from $2.9M to $1.6M — a 45.5% year-over-year decrease (period ending December 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Eiger BioPharmaceuticals reported $1.6M in inventory as of December 2023. That compares with $2.9M in the prior-year period — down 45.5% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current inventory of $1.6M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Eiger BioPharmaceuticals, and consider following EIGRQ for alerts when major investors trade the stock.

Eiger BioPharmaceuticals is classified in the Healthcare sector. On inventory, it currently shows $1.6M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing EIGRQ with unrelated industries.